Personalized medicine promises to deliver the right treatment to the right patient at the right price. Yet the highly individualized nature of personalized medicine – tailoring treatment and dosing to each person’s unique lifestyle, environment (exposures) and genetics (genetic profile) – and its potential costs, raises questions regarding the applicability of personalized medicine on a population-wide basis. And, more specifically, whether personalized medicine, and the massive federal Precision Medicine Initiative and All of Us research program, are likely to have a significant impact on the health of the American public. Join us at the University of Utah for this full-day symposium at which nationally-renowned experts in personalized medicine, genomics, epidemiology, health disparities, regulatory science and bioethics will wrestle with the question whether and how personalized medicine can improve population health.
Friday, March 16, 2018
Health Sciences Education Building, 1730
26 South 2000 East
University of Utah
Salt Lake City, UT 84112
Registration is free, register online
8:00-8:30 a.m. – Breakfast and Registration
8:30-8:40 a.m. – Welcome by Willard Dere, MD and Jorge Contreras, JD
8:40-9:50 a.m. – Co-Opening Keynote Session: Will Personalized Medicine Improve Population Health?
Moderator: Angie Fagerlin, PhD, University of Utah
8:40-9:05 – Muin Khoury, MD, PhD, Centers for Disease
Article originally posted at